|
🐬
|
99mTc-HYNIC-[Tyr3]-octreotide for imaging somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide.
C. Decristoforo,
L. Meléndez-Alafort,
J. Sosabowski,
Stephen J. Mather
|
7 |
2000 |
7
🐬
|
|
🐜
|
Magnetic Drug Targeting: Preclinical in Vivo Studies, Mathematical Modeling, and Extrapolation to Humans.
15 auth.
K. Al‐Jamal,
J. Bai,
J. Wang,
A. Protti,
P. Southern,
L. Bogart,
H. Heidari,
Xinjia Li,
A. Cakebread,
D. Asker,
...
W. Al-Jamal,
A. Shah,
S. Bals,
J. Sosabowski,
Q. Pankhurst
|
7 |
2016 |
7
🐜
|
|
🐜
|
Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging.
33 auth.
Michael Duncan Allen,
P. Luong,
C. Hudson,
J. Leyton,
B. Delage,
E. Ghazaly,
R. Cutts,
Ming Yuan,
N. Syed,
C. Lo Nigro,
L. Lattanzio,
Małgorzata Chmielewska-Kassassir,
I. Tomlinson,
R. Roylance,
H. Whitaker,
...
Anne Warren,
D. Neal,
C. Frezza,
L. Beltrán,
L. Jones,
C. Chelala,
Bor-Wen Wu,
J. Bomalaski,
R. Jackson,
Yong-jie Lu,
T. Crook,
N. Lemoine,
S. Mather,
J. Foster,
J. Sosabowski,
N. Avril,
Chien-Feng Li,
P. Szlosarek
|
6 |
2014 |
6
🐜
|
|
🐜
|
Preclinical In Vivo Modeling of Cytokine Release Syndrome Induced by ErbB-Retargeted Human T Cells: Identifying a Window of Therapeutic Opportunity?
13 auth.
Sjoukje J. C. van der Stegen,
David M. Davies,
S. Wilkie,
J. Foster,
J. Sosabowski,
J. Burnet,
L. Whilding,
R. Petrovic,
S. Ghaem-Maghami,
S. Mather,
...
J. Jeannon,
Ana C. Parente-Pereira,
J. Maher
|
6 |
2013 |
6
🐜
|
|
🐜
|
Cancer associated fibroblast FAK regulates malignant cell metabolism
25 auth.
F. Demircioglu,
Jun Wang,
J. Candido,
Ana S. H. Costa,
P. Casado,
Beatriz de Luxan Delgado,
L. Reynolds,
Jesús Gómez-Escudero,
Emma Newport,
V. Rajeeve,
A. Baker,
Marina Roy-Luzarraga,
T. Graham,
J. Foster,
Yu Wang,
...
J. Campbell,
Rajinder Singh,
Penglie Zhang,
T. Schall,
F. Balkwill,
J. Sosabowski,
P. Cutillas,
C. Frezza,
P. Sancho,
K. Hodivala-Dilke
|
6 |
2020 |
6
🐜
|
|
🐜
|
Membrane Radiolabelling of Exosomes for Comparative Biodistribution Analysis in Immunocompetent and Immunodeficient Mice - A Novel and Universal Approach
12 auth.
F. Faruqu,
J. Wang,
Lizhou Xu,
Luke McNickle,
Eden Ming-Yiu Chong,
A. Walters,
...
M. Gurney,
A. Clayton,
L. Smyth,
R. Hider,
J. Sosabowski,
K. Al‐Jamal
|
6 |
2019 |
6
🐜
|
|
🐜
|
Translocation of LRP1 targeted carbon nanotubes of different diameters across the blood–brain barrier in vitro and in vivo
11 auth.
H. Kafa,
J. Wang,
N. Rubio,
R. Klippstein,
P. M. Costa,
H. A. Hassan,
...
J. Sosabowski,
S. Bansal,
J. Preston,
N. Abbott,
K. Al‐Jamal
|
6 |
2016 |
6
🐜
|
|
🐜
|
Comparative biodistribution of 12 111In-labelled gastrin/CCK2 receptor-targeting peptides
14 auth.
P. Laverman,
Lieke Joosten,
A. Eek,
S. Roosenburg,
P. Peitl,
T. Maina,
H. Mäcke,
L. Aloj,
E. von Guggenberg,
J. Sosabowski,
...
M. de Jong,
J. Reubi,
W. Oyen,
O. Boerman
|
6 |
2011 |
6
🐜
|
|
🐬
|
Radiolabelled peptides for oncological diagnosis
P. Laverman,
J. Sosabowski,
O. Boerman,
W. Oyen
|
6 |
2012 |
6
🐬
|
|
🐜
|
Development of the designed ankyrin repeat protein (DARPin) G3 for HER2 molecular imaging
15 auth.
R. Goldstein,
J. Sosabowski,
M. Livanos,
J. Leyton,
K. Vigor,
Gaurav Bhavsar,
Gabriela Nagy-Davidescu,
Mohammed Rashid,
Enrique Miranda,
Jenny Yeung,
...
B. Tolner,
A. Plückthun,
S. Mather,
T. Meyer,
K. Chester
|
6 |
2014 |
6
🐜
|
